Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (RRID:SCR_007235)Copy Citation Copied
URL: http://www.crash2.lshtm.ac.uk
Proper Citation: Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (RRID:SCR_007235)
Description: This is a trial for a large randomised placebo controlled trial among trauma patients with, or at risk of, significant haemorrhage, of the effects of antifibrinolytic treatment on death and transfusion requirement. Sponsors: This resource is supported by UK NIHR Health Technology Assessment programme, Pfizer, BUPA Foundation, and J P Moulton Charitable Foundation. Keyowrds: Trial, Placebo, Drug, Trauma, Haemorrhage, Antifibrinolytic, Treatment, Death, Transfusion,
Synonyms: Crash-2
Resource Type: narrative resource, data or information resource, topical portal, portal, experimental protocol
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage.
No alerts have been found for Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage.
Source: SciCrunch Registry